Cost-utility Analysis of Dornase alfa in comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis.

Autor: Heydari, Fatemeh Sadat1 heydari.f96@gmail.com
Zdroj: Journal of Pharmacoeconomics & Pharmaceutical Management. Winter2023, Vol. 9 Issue 1, p39-48. 10p.
Databáze: Business Source Ultimate